News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
RESEARCH UPDATES

Characterization of The R6/1 Mouse Model of Huntington’s Disease

August 6, 2024
Read More
RESEARCH UPDATES

Traumatic Brain Injury Model Insights

June 27, 2024
Read More
INDUSTRY NEWS

Back to the future: From target-selective drug design to AI-enabled polypharmacology

May 20, 2024
Read More
RESEARCH UPDATES

Phenotyping of a TDP-43 Mouse Model of ALS

May 20, 2024
Read More

The 17th Annual Global Science Summit & Gala

May 7, 2024
Read More

The 16th Annual Parkinson’s Disease Therapeutics

May 7, 2024
Read More

American College of Neuropsychopharmacology

May 2, 2024
Read More

American Epilepsy Society

May 2, 2024
Read More

Society for Neuroscience

May 2, 2024
Read More